Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$66.81 - $80.83 $194,216 - $234,972
-2,907 Reduced 2.04%
139,510 $10.9 Million
Q1 2024

May 15, 2024

BUY
$61.03 - $69.57 $2.86 Million - $3.26 Million
46,920 Added 49.13%
142,417 $9.65 Million
Q4 2023

Feb 14, 2024

BUY
$61.89 - $69.28 $639,818 - $716,216
10,338 Added 12.14%
95,497 $6.43 Million
Q3 2023

Nov 14, 2023

SELL
$64.85 - $71.7 $5.64 Million - $6.23 Million
-86,903 Reduced 50.51%
85,159 $5.77 Million
Q2 2023

May 17, 2024

BUY
$69.91 - $75.81 $2.07 Million - $2.25 Million
29,645 Added 20.82%
172,062 $12.3 Million
Q2 2023

Aug 14, 2023

SELL
$69.91 - $75.81 $20,973 - $22,743
-300 Reduced 0.17%
172,062 $12.3 Million
Q1 2023

May 17, 2024

BUY
$63.15 - $71.6 $2.26 Million - $2.57 Million
35,851 Added 26.26%
172,362 $12 Million
Q1 2023

May 15, 2023

BUY
$63.15 - $71.6 $2.26 Million - $2.57 Million
35,851 Added 26.26%
172,362 $12 Million
Q4 2022

May 17, 2024

SELL
$54.21 - $70.44 $320,164 - $416,018
-5,906 Reduced 4.15%
136,511 $9.26 Million
Q4 2022

Feb 14, 2023

SELL
$54.21 - $70.44 $104,245 - $135,456
-1,923 Reduced 1.39%
136,511 $9.26 Million
Q3 2022

Nov 14, 2022

BUY
$53.02 - $135.75 $842,646 - $2.16 Million
15,893 Added 12.97%
138,434 $7.59 Million
Q2 2022

Aug 15, 2022

BUY
$59.26 - $71.14 $650,852 - $781,330
10,983 Added 9.85%
122,541 $8.1 Million
Q1 2022

May 16, 2022

BUY
$55.72 - $67.12 $2.33 Million - $2.81 Million
41,892 Added 60.13%
111,558 $7.4 Million
Q4 2021

Feb 14, 2022

SELL
$54.02 - $63.83 $3.36 Million - $3.97 Million
-62,138 Reduced 47.14%
69,666 $4.07 Million
Q3 2021

Nov 15, 2021

BUY
$55.56 - $60.79 $7.32 Million - $8.01 Million
131,804 New
131,804 $7.92 Million

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $224B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main Portfolio

Follow Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main, based on Form 13F filings with the SEC.

News

Stay updated on Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main with notifications on news.